Enumera Molecular

Curated by Signal

Developer of liquid biopsy tools

Overview

Developer of liquid biopsy tools. The company manufactures tools for developing rapid, low-cost solutions for the assessment of biomolecules via liquid biopsy.

Key facts

Founded: 2022
Headquarters: Ann Arbor, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

ActaStim
Provider of a portable device for lumbar spine fusion therapy monitoring
Health TechnologyManassas, United States
Capsule
Provider of an online pharmacy for delivering medicines
Health TechnologyNew York City, United States
1910 Genetics
Developer of small molecule therapeutics to treat pain and aging-related diseases
Health TechnologyCambridge, United States

About Enumera Molecular

What does Enumera Molecular do?

Developer of liquid biopsy tools.

Where is Enumera Molecular headquartered?

Enumera Molecular is headquartered in Ann Arbor, United States.

When was Enumera Molecular founded?

Enumera Molecular was founded in 2022.

Which sector is Enumera Molecular in?

Enumera Molecular operates in Health Technology.

Who are Enumera Molecular's competitors?

Companies similar to Enumera Molecular include ActaStim, Capsule, and 1910 Genetics.